startup

adivo

Development of specific antibodies for veterinary medicine.
  • Life Science & Healthcare
  • Seed Stage
  • Platform
  • B2B
  • 2018
  • 1-10 Employees
  • Found
  • Planegg, DE
  • Login required
  • adivo GmbH
  • Bayern

Profile is not claimed et

This profile is created by the Startbase Analyst Team. If you are a team member of this company you can claim the profile in order to make changes to it.

Is this your company? Claim profile
Markus Waldhuber Geschäftsführer
Kathrin Ladetzki-Baehs Geschäftsführerin

News about adivo

Recent mentions of adivo in podcasts & videos:

Jobs at adivo:

Related companies

High-Tech Gründerfonds
Investor 2005 Bonn High-Tech Gründerfonds HTGF is one of the leading and most active early-stage investors in Germany and Europe.
Startup 2019 Planegg Tubulis Reimagining Antibody Drug Conjugates Protein-drug conjugates by combining proprietary novel technologies with disease-specific biology.
Startup 2017 Freising 4GENE Natural, biotechnologically produced, activatable small molecules marketed as flavor-on-demand to cosmetic and pharmaceutical companies and industrial customers worldwide.
Startup 2010 Planegg Lindis Biotech Development of Triomab® antibodies - a new class of T-cell activating bispecific antibodies that enable the immune system to transform malignant cancers into treatable and potentially curable diseases.
Startup 2017 Planegg ViGeneron Developing innovative gene therapies for the treatment of eye diseases and collaborating with biopharmaceutical companies in other disease areas.

Other Startups nearby

Startup 2010 Planegg Lindis Biotech Development of Triomab® antibodies - a new class of T-cell activating bispecific antibodies that enable the immune system to transform malignant cancers into treatable and potentially curable diseases.
Startup 2013 Planegg Bind-X Industrial applications in the field of biotechnology.
Startup 2016 Planegg SciRhom Developing drugs to combat life-threatening diseases.
Startup 2016 Planegg PreOmics Develops and provides technologies for mass spectrometry-based proteomics.
Startup 2015 Planegg Atriva Therapeutics Antiviral therapies against several severe respiratory viral infections with high unmet medical need, such as influenza and COVID-19.

FYI: English edition available

Hello my friend, have you been stranded on the German edition of Startbase? At least your browser tells us, that you do not speak German - so maybe you would like to switch to the English edition instead?

Go to English edition

FYI: Deutsche Edition verfügbar

Hallo mein Freund, du befindest dich auf der Englischen Edition der Startbase und laut deinem Browser sprichst du eigentlich auch Deutsch. Magst du die Sprache wechseln?

Deutsche Edition öffnen